By Plenary Sessions: Riina Sikkut

The legislative focus is aimed at protecting existing planning processes (such as comprehensive plans and environmental impact assessments) and emphasizing their transparency. There is hope that the Riigikogu will process draft legislation in the future that supports achieving the goal of local green electricity production.

The main legislative priorities include the transposition of the Tobacco Directive (banning flavors in heated products) and the enactment of advance directives for patients. He is a strong supporter of these bills, viewing the advance directive as a means of making existing rights enforceable. He calls for the regulation to be expanded to cover all nicotine products in the future.

Legislative focus is directed toward revising the funding principles for the cultural sector and improving the wages and social guarantees of cultural workers. The speaker is a political lobbyist who is demanding the establishment of a performance-based compensation system, citing the sector's achievements.

The legislative focus is on the field of healthcare and public health, including amendments to the Tobacco Act to ban flavors in heated tobacco products. Another priority is a bill that will make novel treatment options available to Estonian patients. The speaker supports these bills and emphasizes the need to move forward toward broader regulation of nicotine products.

The primary legislative focus is the opposition to the government's planned amendments to the Employment Contracts Act, which pose a threat to worker protection. Furthermore, emphasis is placed on the necessity of changing the law and AKI's operational procedures to improve how registry data is utilized for making better decisions.

The legislative focus centers on reforming tax laws and legal acts governing benefits, with the aim of enhancing equity. The speaker is participating in this process as a member of the Finance Committee, where discussions are taking place regarding the restructuring of a specific tax and the legal basis for broader support measures.

The legislative focus is on amending drug regulation (hospital exemption) to allow the exceptional manufacture of novel medicines when alternatives with marketing authorization are not available in Estonia. The priority is reducing the administrative burden and shortening the deadlines for issuing permits from 120 days to 90 days. The speaker is a strong supporter and drafter of the bill.

The legislative focus is the swift transposition of the EU directive concerning gender balance requirements on the boards of listed companies. The speaker is an active proponent of the draft legislation and is accelerating the process, serving in the capacity of a representative for the lead committee.